71 – 80 of 164
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Human Leucocyte Antigen, Infections and Systemic Inflammatory Biomarkers in Early Atherosclerosis in Children and Adolescents with Type 1 Diabetes
Odermarsky, M. LU
; Pesonen, Erkki
LU
; Maxedius, Annica
LU
; Sorsa, Timo
; Pussinen, Pirkko J
and Liuba, P.
LU
(2015)
49th Annual Meeting of the Association for European Paediatric and Congenital Cardiology
In Cardiology in the Young
25(Suppl. 1).
p.33-33
- Contribution to journal › Published meeting abstract
-
Mark
Safety of device closure of secundum atrial septal defects in children-does the weight at time of procedure matter?
- Contribution to journal › Published meeting abstract
- 2014
-
Mark
On New Implants - The results of five prospective, randomized RSA trials with aspects on phased introduction and continuous migration
- Thesis › Doctoral thesis (compilation)
-
Mark
Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of remission and 5-year drug survival
- Contribution to journal › Scientific review
-
Mark
Safety and Preliminary Efficacy of Ultrasound-guided Percutaneous Irreversible Electroporation for Treatment of Localized Pancreatic Cancer
- Contribution to journal › Article
-
Mark
Safety as a key performance indicator: Creating a safety culture for enhanced passenger safety, comfort, and accessibility
Wretstrand, Anders LU
; Holmberg, Bengt
LU
and Berntman, Monica
LU
(2014)
In Research in Transportation Economics
48.
p.109-115
- Contribution to journal › Article
-
Mark
The fundamental problem of measuring resilience to extreme weather events
- Contribution to conference › Abstract
-
Mark
Proceedings for the CIB W099 Achieving Sustainable Construction Health and Safety,
(2014)
- Book/Report › Conference proceeding (editor)
- 2013
-
Mark
Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients
- Contribution to journal › Article
-
Mark
A topical microemulsion for the prevention of allergic rhinitis symptoms: results of a randomized, controlled, double-blind, parallel group, multicentre, multinational clinical trial (Nares study)
- Contribution to journal › Article